research alliance

Rheos will access data from PatientsLikeMe's DigitalMe biomarker discovery program, which collected molecular and other biological data from participants.

The study, called TRAMmoniTTR, will longitudinally monitor the clinical status of both symptomatic and asymptomatic participants with variants in the TTR gene.

The wastewater analytics firm will work with the two government agencies to analyze samples from treatment plants across the US for SARS-CoV-2 viral elements.

The companies aim to identify biomarkers that can be used to diagnose early-onset Parkinson's disease, as well as track disease progression.

The Regeneron Genetics Center will provide whole-exome sequencing for 150,000 patients who will be able to opt-in to receive actionable results.

Illumina, Twist Bioscience, Western Digital, and Microsoft are teaming up with others to make DNA-based data storage technologies interoperable.

The partners will apply whole-exome and whole-transcriptome analysis to evaluate two existing drugs for squamous cell carcinoma treatment.

The partners plan to build a database of genomic and patient-reported data to identify how genetics can impact disease outcome.

Quidel's preliminary earnings more than doubled over the prior quarter on increasing SARS-CoV-2 test sales.